114 related articles for article (PubMed ID: 3524832)
21. Review of etoposide.
Phillips NC; Lauper RD
Clin Pharm; 1983; 2(2):112-9. PubMed ID: 6309469
[No Abstract] [Full Text] [Related]
22. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
Sanz Ortíz J; Saiz García F
Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
[No Abstract] [Full Text] [Related]
23. [Effect of etoposide for urogenital tumors].
Kinjo T; Murase T; Aota Y; Shimoji T; Mitsuya H
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1267-71. PubMed ID: 4004290
[TBL] [Abstract][Full Text] [Related]
24. [New antineoplastic drugs of the podophyllotoxin derivative group].
Robak T; Płuzańska A
Pol Tyg Lek; 1983 Jan; 38(1):27-30. PubMed ID: 6346283
[No Abstract] [Full Text] [Related]
25. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
[TBL] [Abstract][Full Text] [Related]
26. Etoposide (VP-16-213).
Issell BF; Crooke ST
Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
[No Abstract] [Full Text] [Related]
27. Phase II trial of etoposide in previously treated small cell carcinoma of the lung.
Antman K; Pomfret E; Karp G; Skarin A; Canellos G
Cancer Treat Rep; 1984 Nov; 68(11):1413-4. PubMed ID: 6094004
[No Abstract] [Full Text] [Related]
28. Etoposide in small cell lung cancer resistant to prior chemotherapy.
Asbury RF; Rubins J; Bennett JM
Cancer Treat Rep; 1983 Oct; 67(10):951-2. PubMed ID: 6313187
[No Abstract] [Full Text] [Related]
29. Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.
Linker CA; Damon LE; Ries CA; Rugo HS; Wolf JL
Semin Oncol; 1993 Aug; 20(4 Suppl 4):40-8; quiz 49. PubMed ID: 8342075
[TBL] [Abstract][Full Text] [Related]
30. Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.
Lazarus HM; Gray R; Ciobanu N; Winter J; Weiner RS
Bone Marrow Transplant; 1994 Sep; 14(3):443-8. PubMed ID: 7994270
[TBL] [Abstract][Full Text] [Related]
31. Does etoposide have curative potential?
Ignoffo RJ
Clin Pharm; 1983; 2(2):167. PubMed ID: 6309470
[No Abstract] [Full Text] [Related]
32. VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.
Tempero M; Kessinger A; Lemon HM
Cancer Clin Trials; 1981; 4(2):155-7. PubMed ID: 6265110
[No Abstract] [Full Text] [Related]
33. [Phase II study of NK 171 (etoposide) on malignant lymphomas and acute leukemia. A cooperative study group on NK 171 in hematological malignancies].
Kimura K; Yamada K; Yoshida T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):496-501. PubMed ID: 3954373
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
Chang TT; Gulati SC; Chou TC; Vega R; Gandola L; Ibrahim SM; Yopp J; Colvin M; Clarkson BD
Cancer Res; 1985 Jun; 45(6):2434-9. PubMed ID: 3857119
[TBL] [Abstract][Full Text] [Related]
35. Autologous bone marrow transplantation in neoplasia.
Dicke KA; Vellekoop L; Spitzer G; Zander AR; Schell F; Verma DS
Transplant Proc; 1981 Mar; 13(1 Pt 1):267-9. PubMed ID: 6267751
[No Abstract] [Full Text] [Related]
36. High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study.
Wolff SN; Fer MF; McKay CM; Hande KR; Hainsworth JD; Greco FA
J Clin Oncol; 1983 Nov; 1(11):701-5. PubMed ID: 6366131
[TBL] [Abstract][Full Text] [Related]
37. [Effects of oral etoposide in small cell carcinoma of the lung].
Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Kawakami Y; Shimizu T; Onodera S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1244-7. PubMed ID: 6329103
[TBL] [Abstract][Full Text] [Related]
38. Etoposide by oral route in the treatment of unresectable non-small cell lung cancer.
Scagliotti G; Lodico D; Gozzelino F; Pescetti G
Chemioterapia; 1984 Oct; 3(5):324-6. PubMed ID: 6532545
[TBL] [Abstract][Full Text] [Related]
39. High-dose etoposide in the treatment of relapsed primary brain tumors.
Finn GP; Bozek T; Souhami RL; Slevin ML; Thomas DG
Cancer Treat Rep; 1985 Jun; 69(6):603-5. PubMed ID: 4016766
[TBL] [Abstract][Full Text] [Related]
40. [A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
Wakui A; Yokoyama M; Takahashi H; Yoshida Y; Sakata Y; Sato S; Kano A; Kawamoto K; Hashimoto S; Konno K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):319-29. PubMed ID: 3947109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]